Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

How about another one....

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
kevli33 Member Profile
 
Followed By 8
Posts 925
Boards Moderated 0
Alias Born 05/12/05
160x600 placeholder
BTIG Remains a Buy on Anavex Life Sciences (AVXL) TipRanks - 1/19/2022 1:45:28 AM
Anavex Life Sciences (AVXL) Gets a Buy Rating from H.C. Wainwright TipRanks - 1/11/2022 6:45:12 AM
JonesTrading Reaffirms Their Buy Rating on Anavex Life Sciences (AVXL) TipRanks - 1/10/2022 12:55:34 PM
Anavex Life Sciences Reports Positive Results from Phase 1 Clinical Trial of ANAVEX®3-71 GlobeNewswire Inc. - 1/10/2022 7:00:00 AM
Anavex Life Sciences Promotes Walter E Kaufmann, M.D. to Chief Scientific Officer and Appoints Edward R Hammond, M.D., M.P.H., Ph.D., as Chief Medical Officer GlobeNewswire Inc. - 1/6/2022 7:00:00 AM
Anavex Life Sciences Updates 2 Key Risk Factors TipRanks - 1/6/2022 6:01:37 AM
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference GlobeNewswire Inc. - 1/5/2022 7:00:00 AM
Dawson James Maintains a Buy Rating on Anavex Life Sciences (AVXL) TipRanks - 1/5/2022 4:10:29 AM
Anavex Life Sciences to Present at 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 12/14/2021 7:00:00 AM
Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/29/2021 7:00:00 AM
Anavex Life provides key updates on clinical trials in rare genetic neurological disorders Seeking Alpha - 11/24/2021 9:40:36 AM
Anavex Life Sciences EPS misses by $0.39 Seeking Alpha - 11/24/2021 7:07:01 AM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results GlobeNewswire Inc. - 11/24/2021 7:00:00 AM
Notable earnings after Wednesday's close Seeking Alpha - 11/23/2021 5:35:23 PM
Anavex Life Sciences FY 2021 Earnings Preview Seeking Alpha - 11/23/2021 1:20:23 PM
Notable earnings before Wednesday's open Seeking Alpha - 11/23/2021 10:42:34 AM
Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021 GlobeNewswire Inc. - 11/17/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease GlobeNewswire Inc. - 11/10/2021 7:00:00 AM
Anavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference GlobeNewswire Inc. - 10/15/2021 7:00:00 AM
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease GlobeNewswire Inc. - 10/13/2021 7:00:00 AM
Cassava down after phase 3 simufilam announcement; other Alzheimer's names follow Seeking Alpha - 10/6/2021 12:51:22 PM
CEO Presenting on the Emerging Growth Conference on September 29  Register Now InvestorsHub NewsWire - 9/28/2021 8:00:00 AM
Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access 2021 GlobeNewswire Inc. - 9/27/2021 9:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 8:11:01 AM
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market® GlobeNewswire Inc. - 9/27/2021 7:00:00 AM
kevli33   Tuesday, 01/29/19 12:50:04 PM
Re: Investor2014 post# 179773
Post # of 347205 
How about another one....

Feb 18-21 San Francisco

Alzheimer Society International Congress (ASIC 2019)

ASIC 2019 is a leading forum in Alzheimer research and dementia care. The Congress will highlight the latest accomplishments in Alzheimer research and best practice in patient care.

The theme of the 2019 Congress is “International United Front Against Alzheimer's”.

ASIC 2019 encourages new concepts and hypotheses on the etiology and potential prevention or treatment therapy, and best practice in Alzheimer’s and Dementia care. New ideas and alternatives to Amyloid cascade hypothesis such as Tau hypothesis, Calcium hypothesis, Inflammation hypothesis, Cholinergic and Oxidative stress hypothesis, Glucose hypometabolism, Endocrine pathway, Bacteria-derived metabolites and other new ideas with supporting data are welcome at the ASIC.

NEW FEATURES OF THE ASIC 2019:

<> Presenting latest findings in Alzheimer research and best practices in dementia patient care.
<> Featuring alternative approaches to the amyloid hypothesis.
<> Launching the UNITED FRONT AGAINST ALZHEIMER'S, to fund innovative approaches and clinical trials in Alzheimer's.
<> Formulating a new strategy to find a prevention or a cure of Alzheimer's by 2025.
<> Introducing the GLOBAL VIRTUAL ALZHEIMER COMMUNITY to collaborate in research and practices in dementia patient care.


MEETING VENUE
The ASIC 2019 will be held at the San Francisco Airport CROWNE PLAZA:
1177 Airport Boulevard, Burlingame, CA 94010
The hotel is conveniently located within 1.5 miles from the San Francisco International Airport, and 15 miles from downtown San Francisco. For more information about hotel and reservation, please visit Hotel Information.

Dr. Christopher Missling (*)
Anavex Life Sciences Corp.
New York, NY 10019 USA


http://www.alzint.com/presenters.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences